
Sign up to save your podcasts
Or


Professor Rob Doughty talks about a new combination medicine to New Zealand for the management of congestive heart failure - ‘Entresto’ Sacubitril/ Valsartan. Rob is a cardiologist and holds the Heart Foundation Chair in Heart Health at the University of Auckland. He practices at Auckland City Hospital where he is the leader of the heart failure service and privately at the Auckland Heart group.
By The Goodfellow Unit (University of Auckland)Professor Rob Doughty talks about a new combination medicine to New Zealand for the management of congestive heart failure - ‘Entresto’ Sacubitril/ Valsartan. Rob is a cardiologist and holds the Heart Foundation Chair in Heart Health at the University of Auckland. He practices at Auckland City Hospital where he is the leader of the heart failure service and privately at the Auckland Heart group.

318 Listeners

498 Listeners

37 Listeners

41 Listeners

3,341 Listeners

17 Listeners

20 Listeners

18 Listeners

47 Listeners

1 Listeners

44 Listeners

18 Listeners

2,072 Listeners

14 Listeners

13 Listeners